Skip to content
Unrated Drug recall · FDA · Published May 13, 2013

West-Ward Recalls Nicardipine Hydrochloride Injection Due to Impurity

West-Ward recalls specific lots of Nicardipine Hydrochloride Injection due to failed impurity specifications. Check lot numbers PLNJ1201 and PLNJ1202.

🇺🇸 FDA recall #D-691-2013DrugWest-Ward Pharmaceutical ›
Take action

Contact the company

Recalling firmWest-ward Pharmaceutical Corp.465 Industrial Way W · Eatontown, NJ 07724-2209
✎ GovInfoNow plain-language explainer

West-Ward Pharmaceutical Corp. is recalling Nicardipine Hydrochloride Injection 25 mg/10 mL single-use vials because they contain out-of-specification levels of an impurity called Nitrophenylpuridine Derivative (NPP-D). The recall affects two specific lots distributed nationwide in April and May 2014. No remedy or return instructions are currently listed in the record. Read more at govinfonow.com/recall/47929-west-ward-pharmaceutical-corp-recalls-nicardipine-hydrochloride-injection-25-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/47929-west-ward-pharmaceutical-corp-recalls-nicardipine-hydrochloride-injection-25-mg · Updated October 13, 2026 · FDA enforcement record: FDA #D-691-2013

Cite this page

“West-Ward Recalls Nicardipine Hydrochloride Injection Due to Impurity.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/47929-west-ward-pharmaceutical-corp-recalls-nicardipine-hydrochloride-injection-25-mg. Based on FDA recall #D-691-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-691-2013%22&limit=1).

The FDA announced on May 13, 2013, that West-Ward Pharmaceutical Corp. voluntarily recalled Nicardipine Hydrochloride Injection due to failed impurity specifications. The recall affects lots distributed nationwide.

How to tell if you have it

  • Brand: West-Ward Pharmaceutical
  • Product: Nicardipine Hydrochloride Injection 25 mg/10 mL (2.5 mg/mL), 10 mL single-use vials
  • NDC: 0143-9689-10
  • Lot PLNJ1201 (April 2014) - 16,880 vials
  • Lot PLNJ1202 (May 2014) - 16,960 vials

The hazard

The products failed impurity and degradation specifications due to out-of-specification values for the impurity Nitrophenylpuridine Derivative (NPP-D).

Context

GovInfoNow's records show West-Ward Pharmaceutical Corp. has had 23 other recalls on record since April 13, 2012. Other recent recalls of similar products include the Unichem Bisoprolol/Hydrochlorothiazide Tablets Recall (January 21, 2026), the American Regent niCARdipine Hydrochloride Injection recall (July 24, 2026), and the Par Health Buprenorphine Injections recall (September 8, 2026).

How to tell if you have this one

Look for Nicardipine Hydrochloride Injection 25 mg/10 mL (2.5 mg/mL) in 10 mL single-use vials manufactured by Exela Pharma Sciences and distributed by West-Ward Pharmaceutical Corp. Check the NDC number 0143-9689-10 and lot numbers PLNJ1201 (April 2014) or PLNJ1202 (May 2014).

  • Brand
    West-Ward Pharmaceutical
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Lot Numbers

    Verify if your vials match lot numbers PLNJ1201 or PLNJ1202.

  2. Contact Healthcare Provider

    Speak with your doctor or pharmacist to determine if you have been affected by this recall.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 22 months after the firm started it.

1. Firm started the recall: May 13, 201312. FDA classified it Class III: Jul 11, 201323. Published in FDA’s Enforcement Report: Jul 17, 201334. FDA terminated the recall: Mar 17, 2015420132015
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-691-2013 (May 13, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-691-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA